Biosyent Inc. logo

Biosyent Inc. (RX)

Market Closed
10 Aug, 20:00
TSX-V TSX-V
CA$
15. 00
0
0%
CA$
127.34M Market Cap
- P/E Ratio
0.13% Div Yield
2,200 Volume
- Eps
CA$ 15
Previous Close
Add Transaction
Day Range
14.95 15.51
Year Range
10.65 15.8
Want to track RX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RX closed today higher at CA$15, an increase of 0% from yesterday's close, completing a monthly increase of 2.459% or CA$0.36. Over the past 12 months, RX stock gained 15.0307%.
RX pays dividends to its shareholders, with the most recent payment made on Jun 15, 2026. The next estimated payment will be in In 1 month on Sep 15, 2026 for a total of CA$0.055.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).

RX Chart

People also search for

Reitmans (Canada) Limited
CA$ 2.07
+0.4854%
RET
Reitmans (Canada) Limited
CA$ 2.27
0%

Biosyent Inc. (RX) FAQ

What is the stock price today?

The current price is CA$15.00.

On which exchange is it traded?

Biosyent Inc. is listed on TSX-V.

What is its stock symbol?

The ticker symbol is RX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.13%.

What is its market cap?

As of today, the market cap is 127.34M.

Has Biosyent Inc. ever had a stock split?

No, there has never been a stock split.

Biosyent Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
René C. Goehrum CEO
TSX-V Exchange
CA0906901081 ISIN
CA Country
60 Employees
29 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

BioSyent Inc. is a healthcare company that operates both in Canada and internationally with a focus on the acquisition, licensing, development, and commercialization of pharmaceutical and other healthcare products. Originally known as Hedley Technologies Inc., the company underwent a name change to BioSyent Inc. in June 2006. Since its inception, BioSyent Inc. has been dedicated to addressing a variety of health conditions through its diversified product portfolio. The company’s strategic approach includes selling its products through wholesalers and retail pharmacy chains, ensuring wide accessibility and distribution. Headquartered in Mississauga, Canada, BioSyent Inc. has established itself as a key player in the healthcare sector by focusing on innovative solutions for iron deficiency anemia, polycystic ovarian syndrome symptoms, vaginal health, pain management, and more.

Products and Services

  • FeraMAX Pd Therapeutic 150: A pharmaceutical-grade solution used primarily for the treatment of iron deficiency anemia. This product is distinguished by its high iron content, catering to those with significant iron deficits.
  • FeraMAX Pd Maintenance 45: A chewable iron supplement designed for the preventive care of iron deficiency anemia. Its chewable form factor appeals to users looking for convenient administration options.
  • FeraMAX Pd Powder 15: A powdered iron supplement aimed at the prevention of iron deficiency and iron deficiency anemia. This versatile formulation allows for easy integration into various beverages or soft foods, making it accessible for all ages including infants and children.
  • Tibella: A hormone replacement therapy product containing tibolone, used for managing symptoms associated with menopause. Tibella offers an alternative to traditional hormone replacement therapies for those seeking different options in their symptom management.
  • Inofolic: A natural health supplement targeting symptoms of polycystic ovarian syndrome (PCOS). Inofolic leverages the benefits of inositol to provide a non-pharmaceutical approach to managing PCOS symptoms.
  • RepaGyn: A vaginal suppository designed for the healing of the vaginal mucosa, as well as the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy. It offers a localized treatment option for enhancing vaginal health.
  • Gelclair: A gel formulated to alleviate the pain of oral mucositis, a common side effect of certain cancer treatments. Gelclair addresses the need for effective pain management solutions for patients undergoing chemotherapy or radiotherapy.
  • Cathejell: A lubricant gel with anesthetic properties used to facilitate the insertion of catheters by lubricating and numbing the urethra. This product is essential in medical procedures requiring catheterization, enhancing patient comfort.
  • Combogesic: An over-the-counter medication formulated for the management of mild to moderate acute pain and the reduction of fever in adults. Combogesic represents an innovative blend of commonly used pain relief and fever-reducing agents.
  • Proktis-M: A rectal suppository aimed at promoting the healing of anal and rectal conditions. Its targeted approach ensures direct treatment, providing relief and promoting recovery in the affected areas.

Contact Information

Address: 2476 Argentia Road
Phone: 905-206-0013